Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2012
09/19/2012CN102675429A Virus capping system polypeptide inhibitor for controlling coronavirus
09/19/2012CN102675425A Functional mycobacterium tuberculosis antigen polypeptide and application thereof
09/19/2012CN102675424A Polypeptide drug for resisting Hepatitis B virus X protein
09/19/2012CN102675423A Polypeptide medicine against hepatitis B virus X protein
09/19/2012CN102675422A Polypeptide drug against hepatitis B virus X protein (HBx)
09/19/2012CN102671215A Chitosan nanoparticle composite as well as preparation method and application thereof
09/19/2012CN102199603B Multi-target interfering RNA (Ribonucleic Acid) molecule and application thereof
09/19/2012CN101979595B Dual expression vector for immunostimulatory RNA and HBV target gene silence RNA, construction and application thereof
09/19/2012CN101899421B Recombinant baculovirus and construction method and application thereof
09/19/2012CN101787366B DNA fragment for peculiarly inhibiting Rab27B gene expression and application thereof
09/19/2012CN101643749B Adeno-associated virus carrier, preparation method thereof and application
09/19/2012CN101422620B Cryptosporidum parvum bivalent nucleic acid vaccine and preparation method thereof
09/18/2012US8268986 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
09/18/2012US8268979 Human MutY
09/18/2012US8268976 Flea GABA receptor subunit nucleic acid molecules
09/18/2012US8268798 Low density lipoprotein receptor-mediated siRNA delivery
09/18/2012US8268797 Combination therapy for the treatment of cancer
09/18/2012US8268795 Emergence of a R-type CA2+ channel (CAV 2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage
09/18/2012US8268794 Pharmaceutical containing HIF-1 alpha and HIF-2 alpha expression inhibitor
09/18/2012US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
09/18/2012US8268560 Polymide nucleic acid derivatives, and agents and processes for preparing them
09/18/2012US8268555 Method for combined sequential agent delivery and electroporation for cell structures and use thereof
09/18/2012US8268329 Modified Vaccinia ankara virus variant
09/18/2012US8268325 Modified Vaccinia Ankara virus variant
09/18/2012US8268324 Modified galectin 9 proteins and use thereof
09/18/2012US8268308 Means for the diagnosis and therapy of CTCL
09/18/2012US8268303 Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
09/18/2012US8268302 Cultures, products and methods using umbilical cord matrix cells
09/18/2012CA2647086C Identification of a jak2 mutation in polycythemia vera
09/18/2012CA2516157C Expression vectors comprising the mcmv ie2 promoter
09/18/2012CA2383136C Obg3 globular head and uses thereof for decreasing body mass
09/18/2012CA2378943C Super-active porcine growth hormone releasing hormone analog
09/18/2012CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia
09/18/2012CA2291483C Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
09/18/2012CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
09/18/2012CA2252972C Serum-free production of recombinant proteins and adenoviral vectors
09/18/2012CA2221293C Helper virus-free aav production
09/13/2012WO2012122447A1 Methods of using microrna-26a to promote angiogenesis
09/13/2012WO2012122334A2 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
09/13/2012WO2012122025A2 Vectors conditionally expressing protein
09/13/2012WO2012122015A2 Selective inhibitors of tumor-initiating cells
09/13/2012WO2012121178A1 Tumor angiogenesis inhibitor
09/13/2012WO2012082470A3 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
09/13/2012US20120232130 Methods for inhibiting starvation of a cell
09/13/2012US20120232012 Compositions having antiangiogenic activity and uses thereof
09/13/2012US20120231526 Method for the Purification of Alphavirus Replicon Particles
09/13/2012US20120231524 Chimeric adenoviruses for use in cancer treatment
09/13/2012US20120231060 Antimicrobial hydrogels, methods of preparation thereof, and articles therefrom
09/13/2012US20120231038 Wound Healing Compositions Comprising Biocompatible Cellulose Hydrogel Membranes and Methods of Use Thereof
09/13/2012US20120231003 Ox2 Receptor Homologs
09/13/2012US20120230998 Ip-10 antibodies and their uses
09/13/2012US20120230992 Vegf-related protein
09/13/2012US20120230971 Chromosomal modification involving the induction of double-stranded dna cleavage and homologous recombination at the cleavage site
09/13/2012US20120230954 Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter
09/13/2012CA2828411A1 Vectors conditionally expressing protein
09/12/2012EP2497780A1 TDF-related compounds and analogs thereof
09/12/2012EP2497500A1 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
09/12/2012EP2497493A1 Nebulizable tuberculosis vaccine for transnasal administration comprising paramyxovirus vector
09/12/2012EP2496268A1 Nanoparticle-based gene delivery systems
09/12/2012EP2496260A1 Activity generating delivery molecules
09/12/2012EP2496243A2 Novel compounds for modulating neovascularisation and methods of treatment using these compounds
09/12/2012EP2496238A1 Lipid formulated compositions and methods for inhibiting expression of transthyretin (ttr)
09/12/2012CN102666480A Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct
09/12/2012CN102665761A Activity generating delivery molecules
09/12/2012CN102660580A Construction method of SOD (superoxide dismutase) gene modified mesenchymal stem cell and application thereof
09/12/2012CN102660579A HBx and human IL-12 double-gene recombinant vector and liver caner-resistant vaccine
09/12/2012CN102660567A Method for constructing pGM (granulocyte-macrophage) CSF (colony-stimulating factor)-IRES (internal ribosome entry site)-Rae1-IL (interleukin)21 vector
09/12/2012CN102660551A VHH (variable domain of heavy chain of heavy-chain antibody) antibody gene derived from anti-CyPA (CyclophilinA) animal of family Camelidae, encoded polypeptide, and application thereof
09/12/2012CN102660543A Method, product and application of chemical modification of siRNA sequence using isonucleoside
09/12/2012CN102660542A Cervical carcinoma diagnosis and treatment method based on micro RNA
09/12/2012CN102659980A Method for preparing double hydrophilic thermo-sensitive polymer nano micelles
09/12/2012CN102659979A Preparation method of double-hydrophilic temperature response polymer
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
09/12/2012CN102659938A Glucagon-like-peptide-2 (GLP-2) analogues
09/12/2012CN102657880A Quaternized chitosan/siRNA (small interfering Ribonucleic Acid) composite particles and preparation method thereof
09/12/2012CN102657879A Application of yeast expressing product of gentiana straminea beta-amyrin synthetase gene GsAS in pharmacy
09/12/2012CN102657878A Application of small activating RNA (Ribonucleic Acid) of INTS6 (Homo Sapiens Integrator Complex Subunit 6) gene to preparation of prostate cancer fighting medicament
09/12/2012CN102657877A Examination and monitoring method of immunological recurrent spontaneous abortion
09/12/2012CN102657876A Drug treatment and monitoring method of immunological recurrent spontaneous abortion
09/12/2012CN102657875A ANT1 gene-based targeted immunoliposome, preparation method thereof and application thereof
09/12/2012CN102657874A A hydrogel-encapsulated lentivirus Lingo-1 RNAi complex for repairing nerve injury and a preparation method thereof
09/12/2012CN102657873A Vesicles consisting of amphiphilic polymer and application of vesicles
09/12/2012CN102657854A Multi-epitope vaccine YL66 and application of preparing vaccine for treating tumour
09/12/2012CN102219860B FGFR-Fc fusion protein and applications thereof
09/12/2012CN102219859B Fusion protein for antagonizing angiogenesis inducible factor and application thereof
09/12/2012CN102178958B MBD2-mTEM fused DNA vaccine and preparation method and application thereof
09/12/2012CN102018959B Method and reagent for preventing and treating heart disease
09/12/2012CN101987197B Method and reagent for inhibiting invasiveness of cancer cells
09/11/2012US8263823 Immunocompetent xenograft model
09/11/2012US8263760 Methods and means for treating DNA repeat instability associated genetic disorders
09/11/2012US8263756 Injecting aqueous solution containing an expression vector comprising desired gene; gene therapy wherein hepatocyte growth factor (HGF) gene is introduced by electroporation into kidney to be transplanted
09/11/2012US8263573 Delivery of dsRNA to arthropods
09/11/2012US8263570 Treating picornavirus infection by targeting MicroRNA miR-141
09/11/2012US8263569 Gene silencing
09/11/2012US8263559 Feline granulocyte macrophage colony stimulating factor proteins
09/11/2012US8263546 Prevention and treatment of osteoarthritis
09/11/2012US8263398 Promoter and viral vector containing the same
09/11/2012US8263394 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof
09/11/2012US8263346 Nonhuman model animal lacking the ability to control lymphocyte migration
09/11/2012US8263326 Compounds and methods for modulating activation of NF-κB
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 870